EXHIBIT 10.30


                   Non-Employee Director Compensation Summary

      Boston Life Sciences, Inc.'s (the "Company's") non-employee directors
currently consist of: Henry Brem; Gary Frashier; William L.S. Guinness; Robert
S. Langer, Jr.; Michael J. Mullen; and John T. Preston.

      For the year ended December 31, 2006, the Company's non-employee director
compensation was as follows:



                                                    Per Board and
                                                      Committee       Annual Fee Per
                           2006 Annual Retainer    Meeting Fees (2)  Committee Chaired
                           --------------------    --------------    -----------------
                                                            
William L.S. Guinness (1)     $22,000                   $2,000                  -
Robert S. Langer, Jr.         $22,000                   $2,000            $10,000
Michael J. Mullen             $22,000                   $2,000            $20,000
John T. Preston               $22,000                   $2,000            $10,000


(1)   The annual retainer is pro-rated for non-employee directors who were not
      on the Board for the full year.

(2)   Board and committee fees are paid on a per meeting basis at $2,000 per
      meeting up to a maximum of $2,000 per day (in the case of a board and
      committee meeting on the same day).

      All non-employee directors are reimbursed for ordinary and reasonable
expenses of attending any board or committee meetings.

      Each new non-employee director is automatically granted an option to
purchase 15,000 shares of the Company's common stock ("New Director Options")
upon initial election or appointment (the "Automatic Grant Date"). The exercise
price of any New Director Options granted shall equal the fair market value of
shares of the Company's common stock subject thereto on the Automatic Grant
Date. New Director Options immediately vest as to 1/3 of the shares subject to
such New Director Options with the remaining 2/3 of the shares subject to such
New Director Option vesting in equal monthly installments over two years ("New
Director Option Vesting").

      Each non-employee director is automatically granted an option to purchase
10,000 shares of the Company's common stock each year ("Annual Director
Options"). The Annual Director Options are granted in the fourth quarter of each
calendar year (the "Annual Grant Date"). The exercise price of any Annual
Director Options granted shall equal the fair market value of shares of the
Company's common stock subject thereto on the Annual Grant Date. Annual Director
Options vest in equal monthly installments over two years ("Annual Director
Option Vesting"). Newly elected non-employee directors are eligible to receive
the Annual Director Options in the fourth quarter of the second calendar year of
service.

      If the Company appoints a non-employee chairman, the chairman will be
entitled to an annual retainer of $50,000 (in lieu of the $22,000 that is
received by the other non-employee directors) and per board meeting fees of
$2,000. The non-employee chairman will be automatically granted an option to
purchase 30,000 shares of the Company's common stock upon appointment (in lieu
of the 15,000 shares that is received by other new non-employee directors)
vesting in accordance with the New Director Option Vesting. In addition, the
non-employee chairman will be automatically granted an option to purchase 20,000
shares of the Company's common stock on the Annual Grant Date vesting in
accordance with the Annual Director Option Vesting. The newly elected
non-employee chairman is entitled to receive this annual grant in the fourth
quarter of the second calendar year of service. The exercise price of any
options granted to a non-employee chairman shall equal the fair market value of
shares of the Company's common stock subject thereto on the grant date.